ELECOM Preventive Device Against Flu and Heatstroke
Elecom has released a new thermo-hygrometer which company calls it “goud”. Using the combination of icons, sounds and flashing lights the goud will alert its user when it detects certain level of temperature and humidity which can be fertile ground for flu during the winter season and heatstroke during the summer season. Goud uses a highly sensitive indoor sensor capable of measuring temperature and humidity, alerting you of any high risk atmospheric conditions which can propagate flu or cause heatstroke. Alarm has been used in three forms: icon, sounds and flashing light with two levels of: caution and warning, with configurable alarm display method. Read more
Release of Energy Efficient Infrared LED Wireless Mouse, “IR LED Mouse” by ELECOM
ELECOM has just released 2 series of its energy efficient LED mouse. The new “IR LED Mouse” which just gone on sale boasts battery life by approximately one year thanks to its infrared LED. The infrared LED with a longer wavelength than red or blue visible light reduced driver voltage resulting in lower power consumption. The new series of “IR LED Mouse” left and right buttons use OMRON made switches which are known for their durability and touch. The mouse uses a 2.4GHz wireless band for stable transmission, allowing the user to operate it at a range of 10m on non-magnetic surface and up to 3m on magnetic surfaces such as steel desks. Read more
Development of State of the Art Application Software Capable of Assessing Clinically Relevant Drug-Drug Interactions by Fujitsu Kyushu Systems Limited
A drug-drug interaction or otherwise referred to as DDI is a pharmacological phenomenon whereby the presence of a second drug (inhibitor) alters the behavior and response of the body to a given dose of a first drug (substrate) leading to changes in the efficacy and safety of drugs when the two drugs are administered together, resulting in adverse side effects or even sometimes fatal death.
Generally, many drug candidates are identified by pharmaceutical companies based on highly specialized and target-specific assay systems which were then optimized and carefully screened through meaningful in vitro assays and animal studies; however still a number of these drug candidates fail in clinical trials (or even drop out of the market after they have been released) mostly due to safety reasons, one of them being potentially deadly DDI. Read more
